ArticleInternational journal of molecular sciences2020

ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models.

Dong-Hoon Yeom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.